Contact your local Elanco Representative to find your nearest store
Efficacy and safety of co-administered once-weekly cagrilintide 2.4 mg with once-weekly semaglutide 2.4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
They help boost your metabolism,suppress the appetite, increase your energy and speed up your weight loss results
Theoretically, the two compounds target completely different receptor systems (amylin receptors for cagrilintide, GLP-1/GIP/glucagon for retatrutide), which suggests they could work synergistically without receptor overlap
if one or more of these nutrients is lacking, anemia can develop
You can learn more about Epithalon and fertility on our blog